NIH Awards Training Grant for Research on Intellectual and Developmental Disabilities
October 30, 2020—(BRONX, NY)—Researchers atAlbert Einstein College of Medicine have received a five-year, $1.6 million National Institutes of Health (NIH) grant to train basic and translational scientists whose research focuses on intellectual and developmental disabilities (IDDs) in children. (Source: Einstein News)
Source: Einstein News - October 30, 2020 Category: Universities & Medical Training Source Type: news

NIH Awards $13.8 Million for Studies on the Prevention and Treatment of Alzheimer's Disease
October 5, 2020—(BRONX, N.Y)—Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research atAlbert Einstein College of Medicine andMontefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimer’s disease. (Source: Einstein News)
Source: Einstein News - October 5, 2020 Category: Universities & Medical Training Source Type: news

$111 Million NIH Grant Awarded to Prevent and Treat HIV-Associated Cancers
September 22, 2020—(BRONX, NY)—The widespread use of antiretroviral therapy to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives—but an unfortunate consequence of people living longer with HIV is an increased risk of cancer. For 25 years, theAIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now,Montefiore Health System andAlbert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium. (Source: Einstein News)
Source: Einstein News - September 22, 2020 Category: Universities & Medical Training Source Type: news

Study Finds That Children ’s Immune Response Protects Against COVID-19
September 21, 2020—(BRONX, NY)—The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults. The findings also have important implications for vaccines and drugs being developed to curb COVID-19. The study was published today in Science Translational Medicine and was conducted by scientists atAlbert Einstein College of Medicine,Children’s Hospital at Montefiore (CHAM), and Yale University. (Source: Einstein News)
Source: Einstein News - September 21, 2020 Category: Universities & Medical Training Source Type: news

Forbes Names Albert Einstein College of Medicine a Top Employer in New York
September 11—(BRONX, NY)—Albert Einstein College of Medicine has been ranked by Forbes as one of thebest employers in New York State in 2020. Einstein placed in the top 100 among employers of all sizes and in all sectors. Specifically, the College of Medicine ranked: (Source: Einstein News)
Source: Einstein News - September 11, 2020 Category: Universities & Medical Training Source Type: news

Albert Einstein College of Medicine Receives $16 Million NIH Grant to Study Cellular Process Linked to Alzheimer ’s Disease
September 8, 2020—(BRONX, NY)—Age is the most significant risk factor for Alzheimer’s disease. In the United States, approximately 1 in 10 people over the age of 65 have the disease, and the odds increase to nearly 1 in 3 for those over 85. However, the mechanisms by which aging increases risk are unknown. (Source: Einstein News)
Source: Einstein News - September 8, 2020 Category: Universities & Medical Training Source Type: news

Einstein Welcomes New Class of Medical Students and Introduces Innovative Curriculum Changes
September 8, 2020—(BRONX, NY)—Albert Einstein College of Medicine welcomed a new class of 183 medical students to campus last month with a week of orientation activities that stressed values of community, diversity, and commitment to patient care. Just five months after the COVID-19 pandemic struck the Bronx, Einstein leaders created the nearly all-virtual orientation program and announced a streamlined and enhanced medical school curriculum for all classes. (Source: Einstein News)
Source: Einstein News - September 8, 2020 Category: Universities & Medical Training Source Type: news

NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial
August 18, 2020—(BRONX, NY)—As the search for COVID-19 therapies continues, convalescent plasma—distilled from the blood of people who have recovered from COVID-19—has emerged as a promising treatment option. Now, the National Institutes of Health has awarded Albert Einstein College of Medicine and Montefiore a $4.3 million grant to support a randomized, double-blind, placebo-controlled phase 2 clinical trial that launched in April to evaluate the efficacy of convalescent plasma to treat COVID-19. (Source: Einstein News)
Source: Einstein News - August 18, 2020 Category: Universities & Medical Training Source Type: news

Random Gene Expression is Critical for Stem Cell Function
August 14, 2020—(BRONX, NY)—Chance plays a big part in life—including in how the human body functions. Randomness appears to be inherent in many biological systems and plays an important role even in processes considered tightly controlled or highly coordinated, such as turning genes on and off. (Source: Einstein News)
Source: Einstein News - August 14, 2020 Category: Universities & Medical Training Source Type: news

New $5.1 Million Grant for Einstein-Developed Tests for Breast Cancer Metastasis
August 14, 2020—(BRONX, NY)—Researchers atAlbert Einstein College of Medicine have received a five-year, $5.1 million grant from the National Cancer Institute, part of the National Institutes of Health, to further evaluate novel tests that Einstein researchers have developed for predicting whether primary breast tumors are likely to spread. Such tests can help prevent unnecessary overtreatment and also identify cases that need more aggressive therapy. The principal investigators on the grant areThomas Rohan, M.B.B.S., Ph.D., D.H.Sc., professor and chair of epidemiology& population health at Einstein and Mon...
Source: Einstein News - August 14, 2020 Category: Universities & Medical Training Source Type: news

Understanding 'Chemo Brain' in Children: Researchers Secure $4.6 Million NIH Grant to Identify Those at Risk
August 11, 2020—(BRONX, NY)—Chemotherapy usually cures children diagnosed with acute lymphoblastic leukemia (ALL), but the treatment may hamper brain development and impact key cognitive functions including sensory processing, memory, and attention. Researchers atAlbert Einstein College of Medicine,Children’s Hospital at Montefiore (CHAM), andRutgers Cancer Institute of New Jersey have received a five-year, $4.6 million grant from the National Institutes of Health (NIH) to determine how chemotherapy exerts its damaging effects on the brain. Their long-term objective is to use this information to develop p...
Source: Einstein News - August 11, 2020 Category: Universities & Medical Training Source Type: news

Gut Microbiome Translates Stress Into Sickle Cell Crises
July 30, 2020—(BRONX, NY)—A new study shows how chronic psychological stress leads to painful vessel-clogging episodes—the most common complication of sickle-cell disease (SCD) and a frequent cause of hospitalizations. The findings, made in mice, show that the gut microbiome plays a key role in triggering those episodes and reveals possible ways to prevent them. The research was conducted by scientists atAlbert Einstein College of Medicine and published online today inImmunity. (Source: Einstein News)
Source: Einstein News - July 30, 2020 Category: Universities & Medical Training Source Type: news

Britta Will, Ph.D., Wins Pershing Square Sohn Prize for Cancer Research
July 29, 2020—(BRONX, NY)—Britta Will, Ph.D., assistant professor of medicine and of cell biology atAlbert Einstein College of Medicine, has won a2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research. (Source: Einstein News)
Source: Einstein News - July 29, 2020 Category: Universities & Medical Training Source Type: news

Earle Chambers, Ph.D., M.P.H., Appointed Director of Research in Department of Family and Social Medicine at Einstein and Montefiore
July 28, 2020—(BRONX, NY)—Earle Chambers, Ph.D., M.P.H., has been appointed director of the division of research in the department of family and social medicine atAlbert Einstein College of Medicine andMontefiore Health System. In this role, Dr. Chambers will help determine the priorities and focus of the department’s research agenda and manage the resources available for the research faculty. He is currently an associate professor of family and social medicine and of epidemiology& population health, and a member of the leadership team for theNew York Regional Center for Diabetes Translation Research ...
Source: Einstein News - July 28, 2020 Category: Universities & Medical Training Source Type: news

NIH Awards $9.5 Million for Einstein-Mount Sinai Diabetes Research Center
July 27, 2020—(BRONX, NY)—Albert Einstein College of Medicine has received a $9.5 million, five-year grant from the National Institutes of Health (NIH) to support theEinstein-Mount Sinai Diabetes Research Center (ES-DRC). The multi-institutional center is a leader in basic, translational, clinical, and community-based research and training in type 1 and type 2 diabetes, obesity, and other metabolic disorders. (Source: Einstein News)
Source: Einstein News - July 27, 2020 Category: Universities & Medical Training Source Type: news

Edward Chu, M.D., M.M.S., To Lead Cancer Medicine at Albert Einstein College of Medicine and Montefiore Health System
BRONX, NY (July 22, 2020)—Albert Einstein College of Medicine andMontefiore Health System today announced that Edward Chu, M.D., M.M.S., has been named director of the National Cancer Institute-designatedAlbert Einstein Cancer Center, vice president for cancer medicine at Montefiore Medicine, professor of medicine and of molecular pharmacology; and will hold the Carol and Roger Einiger Professorship of Cancer Medicine at Einstein. In these roles, Dr. Chu will unite Einstein and Montefiore’s cancer programs into a fully integrated research and clinical enterprise. The appointment will be effective October 1, 202...
Source: Einstein News - July 22, 2020 Category: Universities & Medical Training Source Type: news

A Common Blood Test Identifies Which COVID-19 Patients Benefit and Which Are Harmed from Steroid Treatment
July 22, 2020—(BRONX, NY)— A new study led byAlbert Einstein College of Medicine andMontefiore Health System confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial? The research was published today in theJournal of Hospital Medicine. (Source: Einstein News)
Source: Einstein News - July 22, 2020 Category: Universities & Medical Training Source Type: news

Surrogate Coronavirus May Help Researchers Discover Therapies and Vaccines
July 20, 2020—(BRONX, NY)—To study the potentially lethal coronavirus,Albert Einstein College of Medicine scientists have turned a relatively harmless virus into a coronavirus“surrogate” that is much safer to work with. The research was described this month inCell Host& Microbe. (Source: Einstein News)
Source: Einstein News - July 20, 2020 Category: Universities & Medical Training Source Type: news

Ups and Downs in COVID-19 Data May be Caused by Data Reporting Practices, and Not Weekend Gatherings or Poor Health Care
RELEASE ISSUED BY: AMERICAN SOCIETY FOR MICROBIOLOGY (Source: Einstein News)
Source: Einstein News - July 15, 2020 Category: Universities & Medical Training Source Type: news

Philanthropic Gifts Fund COVID-19 Pilot Research Projects at Einstein and Montefiore
July 15, 2020—(BRONX, NY)—As the number of COVID-19 cases continues to rise in the United States and around the world, researchers at Albert Einstein College of Medicine and Montefiore Health System are conducting a range of studies to learn more about the novel coronavirus and blunt the impact of the disease. Now, four Einstein and Montefiore research teams have received pilot funding from Einstein’s Office of the Dean to advance their projects targeting COVID-19. From discovering antiviral compounds and developing monoclonal antibodies, to using artificial intelligence to make clinical decisions and und...
Source: Einstein News - July 15, 2020 Category: Universities & Medical Training Source Type: news

Einstein Researcher Awarded $3.5 Million Grant to Study Brain Changes During Aging
July 6, 2020—(BRONX, N.Y.)—Cognitive neuroscientistHelena Blumen, Ph.D., atAlbert Einstein College of Medicine has received a five-year, $3.5 million grant from the National Institutes of Health (NIH) to study how changes in the brains of older adults affect gait, cognition, and the development of dementia. The study will map brain changes and their effects over time in 200 older adults. (Source: Einstein News)
Source: Einstein News - July 6, 2020 Category: Universities & Medical Training Source Type: news

Montefiore and Einstein Lead Major NYC Health Centers in Publishing Largest Body of Data in the US About Pregnant Women and COVID
Bronx, NY (June 18, 2020)— Researchers atMontefiore Health System andAlbert Einstein College of Medicine, in collaboration with four major New York City academic health centers, published the largest review to date of birth outcomes among women with SARS-COV-2, the novel coronavirus. (Source: Einstein News)
Source: Einstein News - June 19, 2020 Category: Universities & Medical Training Source Type: news

COVID-19 Pandemic Dramatically Increased Out-of-Hospital Cardiac Arrest Cases and Deaths in New York City
JUNE 19, 2020—(BRONX, NY)—The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests and deaths, according to a study co-authored by researchers atAlbert Einstein College of Medicine,Montefiore Health System, and theFire Department of the City of New York (FDNY). (Source: Einstein News)
Source: Einstein News - June 19, 2020 Category: Universities & Medical Training Source Type: news

Einstein Postdoc Juan Carlos Balandr án, Ph.D., Named Pew Latin American Fellow
June 16, 2020—(BRONX, NY)—Juan Carlos Balandrán, Ph.D., ofAlbert Einstein College of Medicine has been named a2020 Pew Latin American Fellow in the Biomedical Sciences by thePew Charitable Trusts. Dr. Balandrán, who studies how leukemic cells escape detection by the immune system, is preparing to conduct his research in the lab ofPaul Frenette, M.D. A native of Mexico, Dr. Balandrán is one of only 10 scientists awarded the fellowship. (Source: Einstein News)
Source: Einstein News - June 16, 2020 Category: Universities & Medical Training Source Type: news

Albert Einstein College of Medicine Awarded $1 Million Challenge Gift for COVID-19 Research from the Price Family Foundation
June 2, 2020—(BRONX, NY)—Albert Einstein College of Medicine has received a $1 million challenge grant from Michael F. Price and the Price Family Foundation to support COVID-19 research. The foundation will match donations to Einstein for research on the novel coronavirus, dollar-for-dollar, up to $1 million. (Source: Einstein News)
Source: Einstein News - June 2, 2020 Category: Universities & Medical Training Source Type: news

Montefiore and Einstein Test a New Drug Combination to Conquer COVID-19
May 26, 2020—(BRONX, NY)—Montefiore Health System andAlbert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection. The new iteration of the trial, known as ACTT 2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: Einstein News)
Source: Einstein News - May 26, 2020 Category: Universities & Medical Training Source Type: news

Einstein Celebrates 62nd Commencement with Historic Virtual Ceremony
May 26, 2020—(BRONX, N.Y)—Later today,Albert Einstein College of Medicine will celebrate the Class of 2020 by holding its first-ever virtual commencement ceremony. The event will honor Einstein’s 202 graduating medical and graduate students and confer them with their well-earned degrees. (Source: Einstein News)
Source: Einstein News - May 26, 2020 Category: Universities & Medical Training Source Type: news

A Promising Drug for the Treatment of Severe Lung Inflammation in COVID-19 Patients: Montefiore-Einstein Scientists Lead Two Trials of Leronlimab
May 21, 2020—BRONX, NY—Montefiore Health System andAlbert Einstein College of Medicine are the first sites in the nation to begin evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19 and the other to treat severely ill COVID-19 patients. They are hopeful that the drug, leronlimab, may prevent the“cytokine storm” that inflames and fatally damages the lungs and other organs of many COVID-19 patients. (Source: Einstein News)
Source: Einstein News - May 22, 2020 Category: Universities & Medical Training Source Type: news

Children Not Immune to Coronavirus: New Study from Pandemic Epicenter Describes Severe COVID-19 Response in Children
NEW YORK (May 19, 2020)— While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care. A new report from pediatric anesthesiologists, infectious disease specialists and pediatricians at theChildren’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine, describes the clinical characteristics and outcomes of children hospitalized with COVID-19, during the early days of the pandemic. (Source: Einstein News)
Source: Einstein News - May 20, 2020 Category: Universities & Medical Training Source Type: news

First-Of-Its-Kind Report Details How New York Children's Hospital Transformed to Provide Care to Adult COVID-19 Patients
NEW YORK (May 4, 2020)— Over the course of two weeks in March, COVID-19 cases at Montefiore grew from two to almost 700. As the health system looked to increase capacity, an inpatient pediatric unit at theChildren’s Hospital at Montefiore (CHAM), quickly became a 40-bed unit that would be home to adult patients. A new, first-of-its-kind report published in theJournal of Pediatrics describes the rapid transformation that took place. The report also shares valuable lessons learned and best practices for healthcare providers throughout the country, who may face a similar situation in the weeks ahead. (Source: Einstein News)
Source: Einstein News - May 5, 2020 Category: Universities & Medical Training Source Type: news

Cancer Patients Face High Mortality from COVID-19
May 1, 2020—(BRONX, NY)—People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers atMontefiore Health System andAlbert Einstein College of Medicine. The study, published today in the online edition of Cancer Discovery, is the largest so far to assess outcomes for patients with cancer who have also been infected with COVID-19. (Source: Einstein News)
Source: Einstein News - May 1, 2020 Category: Universities & Medical Training Source Type: news

Trial of Highly Touted Drug Begins at Montefiore and Einstein
(BRONX, NY)—April 29, 2020—Researchers atMontefiore Health System andAlbert Einstein College of Medicine have begun testing the drughydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI). (Source: Einstein News)
Source: Einstein News - April 29, 2020 Category: Universities & Medical Training Source Type: news

Clinical Trial Begins to See if Convalescent Plasma Can Treat COVID-19
April 29, 2020—(BRONX, NY)—Montefiore Health System,Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating the disease. (Source: Einstein News)
Source: Einstein News - April 29, 2020 Category: Universities & Medical Training Source Type: news

Einstein-Invented Compound Now Being Tested in COVID-19 Clinical Trial
April 28, 2020—(BRONX, NY)—A compound originally discovered byAlbert Einstein College of Medicine’sVern Schramm, Ph.D., is being evaluated by BioCryst Pharmaceuticals, Inc., in Brazil as a treatment for COVID-19 patients. The randomized, double-blind, placebo-controlled trial is funded by the National Institute of Allergy and Infectious Diseases. (Source: Einstein News)
Source: Einstein News - April 28, 2020 Category: Universities & Medical Training Source Type: news

Albert Einstein College of Medicine Holds Early Graduation to Help Confront COVID-19 Pandemic
April 17, 2020—(BRONX, NY)—Answering the call for additional medical workers to join the frontlines of the COVID-19 pandemic, today more than 100 medical students atAlbert Einstein College of Medicine graduated a month early. Many of these newly minted doctors will immediately join the staff of hospitals in New York City, contributing to the heroic efforts of medical teams who are treating patients fighting this devastating disease. (Source: Einstein News)
Source: Einstein News - April 17, 2020 Category: Universities & Medical Training Source Type: news

Slower Clearance of Coronavirus Infection May Explain Why Men Fare Worse Than Women
(BRONX, NY)—April 17, 2020—Researchers atMontefiore Health System andAlbert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19. In collaboration with the Kasturba Hospital for Infectious Diseases in Mumbai, India, the scientists showed for the first time that men clear the virus from their bodies slower than women and found a possible explanation: a potential male-only“reservoir” for coronavirus. (Source: Einstein News)
Source: Einstein News - April 17, 2020 Category: Universities & Medical Training Source Type: news

Einstein Announces Early Graduation to Help Fight the COVID-19 Pandemic
Yesterday, Albert Einstein College of Medicine informed members of the class of 2020 that they may choose to graduate early, on Friday, April 17, if they have completed their curricular requirements. This voluntary opportunity was offered in order to provide support to hospitals as they continue to manage the surge of COVID-19 patients in New York City and beyond. Students also may choose to graduate on the original date of May 26. (Source: Einstein News)
Source: Einstein News - April 10, 2020 Category: Universities & Medical Training Source Type: news

Montefiore and Einstein Begin Clinical Trial for Severely Ill COVID-19 Patients
(BRONX, NY)—April 3, 2020—Montefiore Health System andAlbert Einstein College of Medicine has started treating very sick COVID-19 patients as part of a multicenter trial evaluating a potential therapy for the new disease. The double-blind, placebo-controlled trial is testing whether sarilumab, a drug already approved for treating rheumatoid arthritis, can halt the inflammation that can overwhelm the lungs of COVID-19 patients. A very similar drug yielded promising results in a recent study involving patients in China. (Source: Einstein News)
Source: Einstein News - April 3, 2020 Category: Universities & Medical Training Source Type: news

Clinical Trial for Severely Ill COVID-19 Patients Now Underway at Montefiore-Einstein
(BRONX, NY)—April 3, 2020—Montefiore Health System andAlbert Einstein College of Medicine has started treating very sick COVID-19 patients as part of a multicenter trial evaluating a potential therapy for the new disease. The double-blind, placebo-controlled trial is testing whether sarilumab, a drug already approved for treating rheumatoid arthritis, can halt the inflammation that can overwhelm the lungs of COVID-19 patients. A very similar drug yielded promising results in a recent study involving patients in China. (Source: Einstein News)
Source: Einstein News - April 3, 2020 Category: Universities & Medical Training Source Type: news

Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
April 3, 2020—(BRONX, NY)—Montefiore Health System andAlbert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This treatment has the potential to help people who have serious lung complications as a result of COVID-19. Recruitment for the trial began in March and is still underway. (Source: Einstein News)
Source: Einstein News - April 3, 2020 Category: Universities & Medical Training Source Type: news

Clement Tagoe, M.D., Ph.D., Named Chief of Rheumatology
March 23, 2020—(BRONX, NY)—Clement Tagoe, M.D., Ph.D., has been named chief of the Division of Rheumatology at Einstein and Montefiore, effective April 1. He replaces Chaim Putterman, M.D., who helped make the rheumatology division a national leader in its field during his 26 years here. (Source: Einstein News)
Source: Einstein News - March 23, 2020 Category: Universities & Medical Training Source Type: news

Einstein Students Learn Match Results Amid COVID-19 Crisis
March 20, 2020—(BRONX, NY)—Amid a sobering global pandemic with medical professionals performing heroic work around the world, fourth-year medical students ofAlbert Einstein College of Medicine, a part ofMontefiore, learned today by email where they will begin their residencies at hospitals across the nation. (Source: Einstein News)
Source: Einstein News - March 20, 2020 Category: Universities & Medical Training Source Type: news

Experimental Drug May Prevent Chemotherapy Drug from Damaging the Heart
March 3, 2020—(BRONX, NY)—The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led byAlbert Einstein College of Medicine researchers and involving zebrafish and mice suggests that the experimental drug BAI1 can prevent doxorubicin from damaging the heart without lessening its anti-cancer properties. The study was published online in the journalNature Cancer. (Source: Einstein News)
Source: Einstein News - March 3, 2020 Category: Universities & Medical Training Source Type: news

Michelle Ng Gong, M.D., M.S., Named Chief of Division of Pulmonary Medicine
February 21, 2020—(BRONX, NY)—Michelle Ng Gong, M.D., M.S., an internationally renowned clinician and researcher, has been named chief of the division of pulmonary medicine atAlbert Einstein College of Medicine andMontefiore Health System. Dr. Gong is currently chief of the division of critical care medicine at Einstein and Montefiore, as well as leader of the unified Jay B. Langer Critical Care Network. (Source: Einstein News)
Source: Einstein News - February 21, 2020 Category: Universities & Medical Training Source Type: news

Susan Band Horwitz Wins Prestigious Cancer Research Award for Anti-Tumor Drug Discovery
February 14, 2020—(BRONX, NY)—Susan Band Horwtiz, Ph.D., distinguished professor of molecular pharmacology and the Rose C. Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine, has been awarded the National Foundation for Cancer Research’s (NFCR) 2020 Szent-Györgyi Prize for Progress in Cancer Research. The honor recognizes her pioneering research establishing the mechanism of action of anti-tumor drugs, including Taxol, that are used to treat ovarian, breast, and lung cancers. (Source: Einstein News)
Source: Einstein News - February 14, 2020 Category: Universities & Medical Training Source Type: news

Montefiore and Albert Einstein College of Medicine Secure $5.9 Million NCI Grant to Improve Cancer Care for Minority and Underserved Communities
January 29, 2020—(BRONX, NY)—Montefiore, the University Hospital ofAlbert Einstein College of Medicine, has received a $5.9 million grant from the National Cancer Institute (NCI) to build on its success recruiting minority and underserved patients into cancer clinical trials and delivering the highest quality cancer care. This new grant, part of the NCI Community Oncology Research Program (NCORP), is a continuation of funding first awarded in 2014. (Source: Einstein News)
Source: Einstein News - January 29, 2020 Category: Universities & Medical Training Source Type: news

Reducing Blood Cancer Patients' Need for Transfusions
January 21, 2020—(BRONX, NY)—A clinical trial has found the drug luspatercept significantly reduced the need for blood transfusions in people with lower-risk myelodysplastic syndromes (MDS), a group of bone marrow disorders that leave people with many defective blood cells and too few normal ones. Approval by the Food and Drug Administration (FDA) would make luspatercept the first new drug available to MDS patients in 12 years.Results of the phase 3 clinical trial were published online January 9 in the New England Journal of Medicine (NEJM). (Source: Einstein News)
Source: Einstein News - January 21, 2020 Category: Universities & Medical Training Source Type: news

Einstein and Montefiore Receive Accreditation for Interprofessional Continuing Education
January 16, 2020—(BRONX, NY)—Albert Einstein College of Medicine andMontefiore Health System have received Joint Accreditation for Interprofessional Continuing Education, certifying their ability to provide interprofessional continuing education (IPCE) for members of the medical profession, including physicians, nurses, and pharmacists. Einstein and Montefiore join fewer than 25 combined medical schools and health systems nationally that have received IPCE accreditation. (Source: Einstein News)
Source: Einstein News - January 16, 2020 Category: Universities & Medical Training Source Type: news

Einstein ’s 2020 Stem Cell Symposium Spotlights RNA Biology and Gene Editing
January 13, 2020—(BRONX, NY)—On Friday, January 17, Albert Einstein College of Medicine will host its 4th Stem Cell Symposium. This year’s event will feature lectures from leading investigators in the fields of RNA biology and the use of gene editing in stem cell research. (Source: Einstein News)
Source: Einstein News - January 13, 2020 Category: Universities & Medical Training Source Type: news